Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01604031 |
Title | Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide |
Acronym | TAIL |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Baylor College of Medicine |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |